Hormone imbalance causes treatment-resistant hypertension

April 11, 2018, Queen Mary, University of London
Credit: CC0 Public Domain

British researchers have discovered a hormone imbalance that explains why it is very difficult to control blood pressure in around 10 per cent of hypertension patients.

The team, led by Queen Mary University of London, found that the steroid hormone 'aldosterone' causes salt to accumulate in the bloodstream. The salt accumulation occurs even in on reasonable diets, and pushes up pressure despite use of diuretics and other standard treatments.

Two patients in the study with previously resistant hypertension were able to come off all drugs after a benign aldosterone-producing nodule was discovered in one adrenal and removed at surgery.

High blood pressure is one of the most common and important preventable causes of heart attack, heart failure, stroke and premature death. It affects over 1 billion people across the world and accounts for approximately 10 million potentially avoidable deaths per year.

Most patients can be treated effectively with adjustments to their lifestyle and the use of regular medication. However, in as many as 1 in 10 patients, blood pressure can be difficult to control and is termed 'resistant hypertension'. These patients are at the highest risk of stroke and heart disease because their blood pressure remains uncontrolled.

The new results come from a six-year trial in 314 patients with resistant hypertension, undertaken by investigators in the British Hypertension Society, funded by the British Heart Foundation and the National Institute for Health Research, and published in the journal The Lancet Diabetes & Endocrinology.

Chief Investigator Professor Morris Brown from Queen Mary University of London said: "This has been a wonderful story of using sophisticated modern methods to solve an old problem - why some patients have apparently intractable hypertension. The discovery of salt overload as the underlying cause has enabled us to identify the hormone which drives this, and to treat or cure most of the patients."

Professor Bryan Williams from University College London said: "These results are important because they will change clinical practice across the world and will help improve the blood and outcomes of our patients with resistant hypertension.

"It is remarkable when so many advances in medicine depend on expensive innovation, that we have been able to revisit the use of drugs developed over half a century ago and show that for this difficult-to-treat population of patients, they work really well."

In previous work, the team showed that resistant hypertension is controlled much better by the drug spironolactone (a steroid blocker of aldosterone) than by drugs licensed for use in hypertension. Now they have shown that the superiority of spironolactone is due to its ability to overcome the salt excess in resistant hypertension.

They also found that spironolactone can be substituted, to good effect, by a drug, amiloride, which could be an option for patients unable to tolerate spironolactone.

The research comes from the PATHWAY-2 study, part of a series of studies designed to develop more effective ways of treating . It investigated the hypothesis that resistant was mainly caused by a defect in eliminating salt and water and that the high in these patients would be best treated by additional diuretic therapy to promote and water excretion by the kidneys.

Explore further: PATHWAY-2 uncovers main cause of drug-resistant hypertension, finds old drugs work best

More information: 'Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies' The Lancet Diabetes & Endocrinology, DOI: 10.1016/S2213-8587(18)30071-8

Related Stories

PATHWAY-2 uncovers main cause of drug-resistant hypertension, finds old drugs work best

August 28, 2017
Salt retention is the main culprit behind drug-resistant hypertension (RHTN), with older diuretic medications being the most effective treatment, according to new results from the PATHWAY-2 study.

Old drug performs new tricks

September 21, 2015
Patients with the most dangerous type of high blood pressure will be able to receive far more effective treatment after Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors ...

Simple blood tests lead to improved hypertension treatment in African countries

May 2, 2017
Using two simple blood tests, Western University researchers were able to drastically improve treatment for resistant hypertension across three sites in Nigeria, Kenya and South Africa.

Spironolactone "a clear winner" for resistant hypertension

August 31, 2015
In patients with poor blood pressure control despite treatment with a combination of three drugs ('resistant hypertension'), addition of the diuretic spironolactone was significantly more effective than adding other blood ...

Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health

July 18, 2016
In a study of patients with hypertension, those with resistant hypertension—meaning that their blood pressure remained elevated despite concurrent use of three antihypertensive agents of different classes—had a higher ...

Team discovers genetic cause of rare high blood pressure syndrome

February 6, 2018
Twenty-five years ago, an unusual inherited form of high blood pressure was first described in an Australian family. Its genetic cause, however, had remained elusive. Using modern sequencing methods, an international research ...

Recommended for you

Research team traces pathway to cardioprotection in post-ischemic heart failure

December 11, 2018
During an ischemic attack, the heart is temporarily robbed of its blood supply. The aftermath is devastating: reduced heart contractility, heart cell death, and heart failure. Contributing to these detrimental changes is ...

Macrophage cells key to helping heart repair—and potentially regenerate, new study finds

December 11, 2018
Scientists at the Peter Munk Cardiac Centre have identified the type of cell key to helping the heart repair and potentially regenerate following a heart attack.

Study reveals new link between atrial fibrillation and mutations in heart disease gene

December 11, 2018
Atrial fibrillation (Afib), a heart condition that causes a rapid, irregular heartbeat that increases a person's risk of stroke and heart failure, is fairly common among older adults. However, its early onset form is relatively ...

Workplace exposure to pesticides and metals linked to heightened heart disease risk

December 11, 2018
Workplace exposure to metals and pesticides is linked to a heightened risk of heart disease in Hispanic and Latino workers, reveals research published online in the journal Heart.

Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes

December 11, 2018
Researchers have found that incidence of heart failure was around two-fold higher in people with diabetes.

Study: Age, race differences determine risk of stroke in women and men

December 11, 2018
A new study found that, between the ages of 45 and 74 years, white women were less likely to have a stroke than white men, but at age 75 and older, there was no difference in stroke risk between white women and men. In contrast, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.